DB12267

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkbp:approvalYear 2020
gptkbp:ATCCode J05AB16
gptkbp:bioavailability low oral bioavailability
gptkbp:CASNumber 1809249-37-3
gptkbp:contraindication hypersensitivity to remdesivir
gptkbp:developer gptkb:Gilead_Sciences
gptkbp:drugClass antiviral drug
gptkbp:form solution for injection
lyophilized powder
gptkbp:halfLife 1 hour (plasma), 25 hours (metabolite)
gptkbp:hasBoxedWarning none
gptkbp:hasEliminationRoute renal
gptkbp:hasFirstApprovalCountry gptkb:United_States
gptkbp:hasFirstApprovalDate 2020-10-22
gptkbp:hasInChIKey RWWYLEGWBNMMLJ-YSOARWBDSA-N
gptkbp:hasMolecularFormula C27H35N6O8P
gptkbp:hasPatentExpiry 2035
gptkbp:hasPatentHolder gptkb:Gilead_Sciences
gptkbp:hasResearchUse gptkb:COVID-19
gptkb:MERS-CoV
gptkb:Ebola_virus
gptkb:Marburg_virus
gptkbp:hasSMILES CC(C)[C@@H](NC(=O)[C@@H]1O[C@]([C@@H](O)[C@H](COP(=O)(O)O)[C@H]1O)(C)O)C#N
gptkbp:hasStorageCondition store below 30°C
gptkbp:hasUNII 53J0A36V2S
https://www.w3.org/2000/01/rdf-schema#label DB12267
gptkbp:indication gptkb:COVID-19
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction RNA polymerase inhibitor
gptkbp:metabolism hydrolysis and phosphorylation
gptkbp:molecularWeight 602.6 g/mol
gptkbp:name gptkb:Remdesivir
gptkbp:pregnancyCategory Not assigned
gptkbp:PubChem_CID gptkb:DB12267
121304016
CHEMBL2016761
D11472
gptkbp:routeOfAdministration intravenous
gptkbp:sideEffect nausea
elevated liver enzymes
hypersensitivity
gptkbp:status FDA approved
gptkbp:synonym gptkb:Veklury
gptkb:GS-5734
gptkbp:target RNA-dependent RNA polymerase
gptkbp:therapeuticArea gptkb:disease
gptkbp:WHOModelListOfEssentialMedicines not listed
gptkbp:bfsParent gptkb:Brigatinib
gptkbp:bfsLayer 7